Buti, Maria <br/><br/>
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Jan 2016 
 - 32-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1093/cid/civ722  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amides<br/>Antiviral Agents--administration & dosage<br/>Benzofurans--administration & dosage<br/>Carbamates<br/>Cyclopropanes<br/>Drug Resistance, Viral--genetics<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Imidazoles--administration & dosage<br/>Quinoxalines--administration & dosage<br/>Ribavirin--administration & dosage<br/>Salvage Therapy--methods<br/>Sulfonamides<br/>Treatment Outcome